Current surveillance from WHO and CDC shows no emerging pathogen with sustained, efficient human-to-human transmission capable of triggering a WHO pandemic declaration by end-2027. Ongoing outbreaks, including Bundibugyo Ebola virus disease in the DRC and Uganda (over 2,100 confirmed cases, largely regional with high case fatality but limited international chains) and sporadic H5N1 avian influenza cases tied to animal exposure, lack evidence of efficient person-to-person spread. Mpox's prior PHEIC ended in 2025, SARS-CoV-2 circulation remains moderate without new variants of concern, and post-COVID population immunity has reduced emergence probabilities for related sarbecoviruses per recent modeling. Enhanced global surveillance, combined with the short timeframe, underpins the market-implied 80% odds for "No," though experts note rising zoonotic pressures from environmental factors over longer horizons.